cbdMD, Inc. (NYSEAMERICAN:YCBD) Sees Large Increase in Short Interest

cbdMD, Inc. (NYSEAMERICAN:YCBD) was the recipient of a large growth in short interest in the month of April. As of April 30th, there was short interest totaling 931,108 shares, a growth of 188.8% from the April 15th total of 322,354 shares. Based on an average trading volume of 6,453,086 shares, the short-interest ratio is currently 0.1 days. Currently, 9.5% of the company’s stock are sold short.

cbdMD Trading Up 1.8%

YCBD stock opened at $0.81 on Friday. cbdMD has a fifty-two week low of $0.47 and a fifty-two week high of $2.56. The business’s 50 day moving average price is $0.78 and its two-hundred day moving average price is $0.88.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in cbdMD stock. Jane Street Group LLC bought a new position in shares of cbdMD, Inc. (NYSEAMERICAN:YCBD) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 51,141 shares of the company’s stock, valued at approximately $69,000. Jane Street Group LLC owned 0.49% of cbdMD as of its most recent filing with the Securities and Exchange Commission. 7.18% of the stock is currently owned by institutional investors and hedge funds.

About cbdMD

cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.

The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.